Back    Zoom +    Zoom -
<IPO>NOVOSENSE (688052.SH) Clears HKEX Listing Hearing
Recommend
3
Positive
6
Negative
3
Mainland A-share listed company NOVOSENSE (688052.SH) passed the listing hearing of the Hong Kong Stock Exchange, with joint sponsors being CITIC Securities, CICC, and CCBI.

The announcement showed that NOVOSENSE is a pioneering analog chip provider in Mainland China, operating under a fabless light asset model, focusing on chip R&D and design while outsourcing manufacturing to third parties.

Related NewsDaiwa Foresees Slower Foreign Capital Return into CN Stock Mkt Next Yr
In 2024, NOVOSENSE ranked fifth among Mainland manufacturers in terms of analog chip revenue, first among Mainland manufacturers of automotive analog chips, and second among global fabless manufacturers.
AASTOCKS Financial News
Website: www.aastocks.com